NERV: Minerva Neurosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Minerva Neurosciences Inc (NERV).
$15.54M Market Cap.
NERV Market Cap. (MRY)
NERV Shares Outstanding (MRY)
NERV Assets (MRY)
Total Assets
$37.14M
Total Liabilities
$62.84M
Total Investments
$0
NERV Income (MRY)
Revenue
$0
Net Income
$1.44M
Operating Expense
$21.85M
NERV Cash Flow (MRY)
CF Operations
-$19.55M
CF Investing
$0
CF Financing
$0
NERV Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $37,143,744 (-34.72%) | $56,899,750 (3.29%) | $55,087,233 (-28.57%) | $77,121,918 (33.83%) |
Assets Current | $22,268,903 (-46.98%) | $42,002,440 (4.59%) | $40,158,941 (-35.44%) | $62,201,439 (126.68%) |
Assets Non-Current | $14,874,841 (-0.15%) | $14,897,310 (-0.21%) | $14,928,292 (0.05%) | $14,920,479 (-50.57%) |
Goodwill & Intangible Assets | $14,869,399 (-0.11%) | $14,886,426 (-0.17%) | $14,911,966 (-0.06%) | $14,920,479 (0.34%) |
Shareholders Equity | -$25,693,100 (9.71%) | -$28,457,490 (-42.12%) | -$20,024,219 (-351.07%) | $7,975,643 (-84.86%) |
Property Plant & Equipment Net | $5,442 (-50.00%) | $10,884 (-33.33%) | $16,326 (0%) | $0 (0%) |
Cash & Equivalents | $21,462,008 (-47.67%) | $41,012,575 (13.31%) | $36,193,606 (-40.52%) | $60,855,080 (139.05%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $1,607,844 (-10.94%) | $1,805,320 (86.18%) | $969,667 (-47.68%) | $1,853,215 (86.14%) |
Accumulated Retained Earnings (Deficit) | -$395,376,563 (0.36%) | -$396,815,428 (-8.18%) | -$366,810,075 (-9.59%) | -$334,701,399 (-17.52%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $60,000,000 (-26.84%) | $82,016,823 (11.23%) | $73,733,876 (11.17%) | $66,327,321 (59531.32%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $60,000,000 (-26.84%) | $82,016,823 (11.23%) | $73,733,876 (11.17%) | $66,327,321 (0%) |
Total Liabilities | $62,836,844 (-26.38%) | $85,357,240 (13.64%) | $75,111,452 (8.63%) | $69,146,275 (1293.06%) |
Liabilities Current | $2,836,844 (-15.08%) | $3,340,417 (142.49%) | $1,377,576 (-51.13%) | $2,818,954 (-10.80%) |
Liabilities Non-Current | $60,000,000 (-26.84%) | $82,016,823 (11.23%) | $73,733,876 (11.17%) | $66,327,321 (3577.99%) |
NERV Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $9,949,791 (-4.46%) | $10,414,323 (-1.59%) | $10,582,239 (-20.59%) | $13,326,710 (-22.92%) |
Research & Development Expense | $11,898,595 (-6.35%) | $12,705,253 (-13.27%) | $14,649,087 (-54.28%) | $32,038,947 (45.37%) |
Operating Expenses | $21,848,386 (-5.50%) | $23,119,576 (-8.37%) | $25,231,326 (-44.38%) | $45,365,657 (15.35%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | -$1,803,356 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $1,438,865 (104.80%) | -$30,005,353 (6.55%) | -$32,108,676 (35.66%) | -$49,905,952 (-2671.45%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $1,438,865 (104.80%) | -$30,005,353 (6.55%) | -$32,108,676 (35.66%) | -$49,905,952 (-2671.45%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $1,438,865 (104.80%) | -$30,005,353 (6.55%) | -$32,108,676 (35.66%) | -$49,905,952 (-2671.45%) |
Weighted Average Shares | $7,568,981 (16.33%) | $6,506,372 (21.84%) | $5,340,194 (-0.00%) | $5,340,196 (4.65%) |
Weighted Average Shares Diluted | $7,573,763 (16.41%) | $6,506,372 (21.84%) | $5,340,194 (-0.00%) | $5,340,196 (4.41%) |
Earning Before Interest & Taxes (EBIT) | $1,438,865 (104.80%) | -$30,005,353 (6.55%) | -$32,108,676 (37.91%) | -$51,709,308 (-2764.37%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$21,848,386 (5.50%) | -$23,119,576 (8.37%) | -$25,231,326 (44.38%) | -$45,365,657 (-2556.52%) |
NERV Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | -$16,326 (0%) | $0 (0%) |
Net Cash Flow from Financing | $0 (0%) | $19,603,701 (392074120.00%) | -$5 (-100.00%) | $60,000,000 (353.24%) |
Net Cash Flow from Operations | -$19,550,567 (-32.23%) | -$14,784,732 (40.01%) | -$24,645,143 (-0.18%) | -$24,601,872 (27.26%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$19,550,567 (-505.70%) | $4,818,969 (119.54%) | -$24,661,474 (-169.67%) | $35,398,128 (797.44%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | -$16,326 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $60,000,000 (0%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $19,999,994 (0%) | $0 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $1,325,525 (-32.66%) | $1,968,381 (-52.09%) | $4,108,819 (-21.27%) | $5,218,994 (-46.22%) |
Depreciation Amortization & Accretion | $22,469 (-27.48%) | $30,982 (263.94%) | $8,513 (-91.64%) | $101,786 (-42.23%) |
NERV Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -4.50% (-103.28%) | 137.00% (-53.72%) | 296.00% (274.32%) | -169.80% (-4142.86%) |
Return on Average Assets (ROAA) | 3.30% (106.56%) | -50.30% (1.95%) | -51.30% (-0.79%) | -50.90% (-1796.67%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 2.10% (105.38%) | -39.00% (14.10%) | -45.40% (35.79%) | -70.70% (-605.00%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 11.69 (976.54%) | -1.33 (-403.40%) | -0.27 (61.31%) | -0.69 (-101.46%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | -0.6 (59.96%) | -1.51 (-256.37%) | -0.42 (-109.88%) | 4.29 (126.32%) |
Debt to Equity Ratio (D/E) | -2.45 (18.44%) | -3 (20.05%) | -3.75 (-143.26%) | 8.67 (9123.40%) |
Earnings Per Share (EPS) | 0.19 (104.12%) | -4.61 (23.29%) | -6.01 (35.72%) | -9.35 (-2437.50%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.58 (-13.69%) | -2.27 (50.80%) | -4.62 (-0.24%) | -4.61 (30.49%) |
Book Value Per Share (BVPS) | -3.4 (22.38%) | -4.37 (-16.64%) | -3.75 (-351.00%) | 1.49 (-85.52%) |
Tangible Assets Book Value Per Share (TABVPS) | 2.94 (-54.42%) | 6.46 (-14.17%) | 7.52 (-35.41%) | 11.65 (39.01%) |
Enterprise Value Over EBIT (EV/EBIT) | 34 (1233.33%) | -3 (-200.00%) | -1 (0.00%) | -1 (-102.86%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 33.47 (1422.85%) | -2.53 (-103.21%) | -1.25 (-93.93%) | -0.64 (-102.02%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 7.85 (-37.57%) | 12.57 (-56.87%) | 29.15 (32.12%) | 22.07 (154.12%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$19,550,567 (-32.23%) | -$14,784,732 (40.05%) | -$24,661,469 (-0.24%) | -$24,601,872 (27.26%) |
Enterprise Value (EV) | $48,907,759 (-35.51%) | $75,832,158 (89.68%) | $39,978,995 (20.68%) | $33,126,840 (-50.85%) |
Earnings Before Tax (EBT) | $1,438,865 (104.80%) | -$30,005,353 (6.55%) | -$32,108,676 (37.91%) | -$51,709,308 (-2764.37%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $1,461,334 (104.88%) | -$29,974,371 (6.62%) | -$32,100,163 (37.80%) | -$51,607,522 (-2537.83%) |
Invested Capital | $57,975,493 (-27.24%) | $79,677,155 (4.37%) | $76,337,961 (17.71%) | $64,854,726 (355.09%) |
Working Capital | $19,432,059 (-49.74%) | $38,662,023 (-0.31%) | $38,781,365 (-34.69%) | $59,382,485 (144.57%) |
Tangible Asset Value | $22,274,345 (-46.98%) | $42,013,324 (4.58%) | $40,175,267 (-35.41%) | $62,201,439 (45.48%) |
Market Capitalization | $15,536,551 (-63.88%) | $43,009,447 (406.54%) | $8,490,907 (-75.19%) | $34,219,974 (-65.73%) |
Average Equity | -$32,110,716 (-46.57%) | -$21,908,164 (-101.97%) | -$10,847,110 (-136.90%) | $29,399,088 (-36.86%) |
Average Assets | $44,189,334 (-25.97%) | $59,690,860 (-4.66%) | $62,605,828 (-36.09%) | $97,959,459 (51.99%) |
Invested Capital Average | $69,941,690 (-8.98%) | $76,846,249 (8.74%) | $70,671,841 (-3.41%) | $73,165,764 (428.30%) |
Shares | 6,993,406 (0.00%) | 6,993,406 (30.96%) | 5,340,193 (-0.00%) | 5,340,196 (0.11%) |
